RVPH: the balance sheet

MyFinsight

For the year ending 2025-12-31, RVPH has $15,923,198 in assets. $7,275,553 in debts. $14,438,792 in cash and cash equivalents.

Balance Sheets	2025-12-31
Cash and cash equivalents	14,438,792
Prepaid clinical trial costs	0
Prepaid expenses and other current assets	664,685
Total current assets	15,103,477
Non-current prepaid clinical trial costs	819,721
Total assets	15,923,198

Short-term debt	406,875
Accounts payable	3,009,074
Accrued clinical expenses	2,582,094
Accrued compensation	485,899
Other accrued liabilities	791,611
Total current liabilities	7,275,553
Warrant liabilities	0
Total liabilities	7,275,553
Common stock, par value of 0.0001 515,000,000 and 315,000,000 shares authorized 5,842,497 and 2,328,960 shares issued and outstanding as of december 31, 2025 and 2024, respectively	11,655
Additional paid-in capital	192,773,942
Accumulated deficit	-184,137,952
Total stockholders' equity	8,647,645
Total liabilities and stockholders equity	15,923,198

Unit: Dollar.